Work

635eP The necessity of adding anti-HER2 antibody to TKI in trastuzumab-resistant, HER2-positive ABC: A multicenter real-world study

Year: 2025

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.1057

Authors: R. Song, X. Peng, Y. Fan, B. Xu, B. Lan, F. Ma

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415942259

FWCI:

Cites:

Cited by:

Related to: 10